Levetiracetam induced obsessive-compulsive disorder in a patient of epilepsy
- PMID: 40786225
- PMCID: PMC12331002
- DOI: 10.4103/indianjpsychiatry_355_25
Levetiracetam induced obsessive-compulsive disorder in a patient of epilepsy
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
Obsessive-compulsive behavior induced by levetiracetam.J Child Neurol. 2015 Jun;30(7):942-4. doi: 10.1177/0883073814541471. Epub 2014 Jul 9. J Child Neurol. 2015. PMID: 25008911
-
Clinical characteristics of obsessive-compulsive disorder comorbid with obsessive -compulsive personality disorder: subtype implications.Front Psychiatry. 2025 Jul 14;16:1577042. doi: 10.3389/fpsyt.2025.1577042. eCollection 2025. Front Psychiatry. 2025. PMID: 40727850 Free PMC article.
-
Systematic Review and Meta-Analysis of Individual Participant Data: Randomized, Placebo-Controlled Trials of Selective Serotonin Reuptake Inhibitors for Pediatric Obsessive-Compulsive Disorder.J Am Acad Child Adolesc Psychiatry. 2025 Jul;64(7):775-785. doi: 10.1016/j.jaac.2025.01.001. Epub 2025 Jan 10. J Am Acad Child Adolesc Psychiatry. 2025. PMID: 39799995
-
Transcranial magnetic stimulation for the treatment of obsessive-compulsive disorder.Cochrane Database Syst Rev. 2003;2003(3):CD003387. doi: 10.1002/14651858.CD003387. Cochrane Database Syst Rev. 2003. PMID: 12917964 Free PMC article.
-
Sleep disorders in patients with obsessive-compulsive disorder: A systematic review of the literature.J Sleep Res. 2025 Aug;34(4):e14446. doi: 10.1111/jsr.14446. Epub 2024 Dec 30. J Sleep Res. 2025. PMID: 39740046
References
-
- Shukla G, Gupta A, Agarwal P, Poornima S. Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine—A retrospective comparison study of North Indian patients with refractory epilepsy. Epilepsy Behav. 2016;64:216–8. - PubMed
-
- Goodman WK, Price LH, Rasmussen SA, Mazure C, Fleischmann RL, Hill CL, Charney DS. The Yale-Brown obsessive compulsive scale: I. Development, use, and reliability. Archives of general psychiatry. 1989;46:1006–11. - PubMed
-
- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–45. - PubMed
-
- Whiteside SP, Port JD, Deacon BJ, Abramowitz JS. A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety. Psychiatry Res. 2006;146:137–47. - PubMed
-
- Doobay M, Sharma V, Eccles H. Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: A pragmatic review. Expert Rev Neurother. 2022;22:721–31. - PubMed
Publication types
LinkOut - more resources
Full Text Sources